News | April 08, 2025
Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Findings likely to generate hypotheses about potential new uses of drugs
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Fexuprazan has the longest half-life of 9 hours among potassium-competitive acid blockers
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
The company expects to launch this product through its marketing partner in the near future
The portfolio includes branded injectable cephalosporines for infectious diseases
The IND application supports the next phase of development of SBO-154
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Subscribe To Our Newsletter & Stay Updated
